Bavarian Nordic A/S BAVA

COP: BAVA | ISIN: DK0015998017 2/01/2025

198,90 DKK (+5,04%)

(+5,04%) 2/01/2025

Grafiek Bavarian Nordic A/S

Grafiek Bavarian Nordic A/S

1 dag1d 5,04%
1 week1w 2,45%
1 maand1m 2,79%
3 maanden3m -13,33%
6 maanden6m 15,10%
1 jaar1j 9,17%
5 jaar5j 15,07%

Bavarian Nordic A/S in het nieuws

Toon enkel gratis nieuws

16 december 2024 · Bavarian Nordic Enters License and Manufacturing Agreement for its Mpox Vaccine with Serum Institute of India · Persbericht

13 december 2024 · Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such · Persbericht

13 december 2024 · New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic · Persbericht

11 december 2024 · Bavarian Nordic to Launch DKK 150 Million Share Buy-back Program · Persbericht

29 november 2024 · Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such · Persbericht

29 november 2024 · Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise · Persbericht

15 november 2024 · Bavarian Nordic Announces Interim Results for the First Nine Months of 2024 · Persbericht

29 oktober 2024 · First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic’s Mpox Vaccine · Persbericht

26 september 2024 · Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines · Persbericht

26 september 2024 · Bavarian Nordic Upgrades its Financial Guidance for 2024 · Persbericht

Profiel Bavarian Nordic A/S

CEO: Paul Chaplin

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe